Based in ICON’s Clinical Pharmacology Unit in San Antonio, US, Elahi will lead ICON’s early phase glucose clamping...
Based in ICON’s Clinical Pharmacology Unit in San Antonio, US, Elahi will lead ICON’s early phase glucose clamping...
Steve leaves Lundbeck UK after 14 years where he held a variety of senior commercial roles.
, Kowa Research Europe Ltd. and Kowa Pharmaceuticals Europe Ltd. Boards have appointed Mr. Gilles Picard as President...
As a Senior Scientist, Matt brings to ERT a wealth of first-hand experience in designing, implementing, and leveraging...
He will take up his new position on April 1st, 2014, reporting directly to Christel Bories, Deputy CEO of the Ipsen...
For six years (2002-8) Zinta was Managing Director of the Turkish arm of Boehringer Ingelheim and for the last 12...
Henk was at Plant Genetic Systems for a decade, first as a researcher and then as a business development manager....
Hoefer has gained more than 20 years of international non-clinical development and management experience in academic...
deBethizy brings more than 20 years of experience in managing and financing life science related technologies, and has...
Kilbee will be responsible for driving the portfolio globally including increased emphasis on digital and content
Dr Dani Bach (formerly of Index Ventures) joins as Managing Partner, Dr Jacques Mizrahi joins in a consulting role as...
Tasker will lead the Company’s clinical development activities as it advances its rich pipeline of novel GPCR-targeted...
Annika has over twenty years’ experience in the healthcare sector, both as a sell-side analyst and investor. She has a...
John’s career spans twenty years, with extensive experience leading and working with international healthcare...
oseph Bisaha has been named Vice President, Clinical Operations and Project Management, and David Jackson Vice...